Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

Mark Gurnell; Andrew Menzies-Gow; Liam G Heaney; Jonathan  Corren; Elisabeth H Bel; Jorge F Maspero; Timothy  Harrison; David Jackson; David Price; Njira Lugogo; James  Kreindler; Annie Burden; Alex  de Giorgio-Miller; Kelly  Padilla; Ubaldo J.  Martin; Esther Garcia Gil

doi:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472

Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

Mark Gurnell
, Andrew Menzies-Gow
, Liam G Heaney
, Jonathan Corren
, Elisabeth H Bel
, Jorge F Maspero
, Timothy Harrison
, David Jackson
, David Price
, Njira Lugogo
, James Kreindler
, Annie Burden
, Alex de Giorgio-Miller
, Kelly Padilla
, Ubaldo J. Martin
, Esther Garcia Gil

Cambridge Biomedical Campus
University of Amsterdam
Fundación CIDEA
University College London Hospitals NHS Foundation Trust
King's College London
Observational and Pragmatic Research Institute Singapore
University of Michigan, Ann Arbor
AstraZeneca
AstraZeneca
National Health Service
Queen's University Belfast
David Geffen School of Medicine at UCLA and Allergy Medical Clinic Inc
University of Nottingham
AstraZeneca, Wilmington
AstraZeneca, US
AstraZeneca, Gaithersburg

Research output: Contribution to journal › Abstract › peer-review

13 Downloads (Pure)

Abstract

Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes
adverse effects, including adrenal insufficiency (AI).

Original language	English
Article number	A1472
Number of pages	1
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	203
Early online date	19 May 2021
DOIs	https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472
Publication status	Published - 2021
Event	ATS International Conference Committee: ATS 2021 - Virtual event Duration: 14 May 2021 → 19 May 2021 https://conference.thoracic.org/

Access to Document

10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472Licence: Unspecified

GurnelL_et_al_ATS_AdrenalInsufficiencyIsNotaBarrier_AAM
Originally Published in: [Authors]. [Article Title]. [Journal Name] [Year];[Volume]:[Pages]. DOI: [Number] Copyright © 2021 by the American Thoracic Society The final publication is available at [Link].
Accepted author manuscript, 142 KBLicence: Other

Cite this

Gurnell, M., Menzies-Gow, A., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J. F., Harrison, T., Jackson, D., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Padilla, K., Martin, U. J., & Gil, E. G. (2021). Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study. American Journal of Respiratory and Critical Care Medicine, 203, Article A1472. https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472

Gurnell, M, Menzies-Gow, A, Heaney, LG, Corren, J, Bel, EH, Maspero, JF, Harrison, T, Jackson, D, Price, D, Lugogo, N, Kreindler, J, Burden, A, de Giorgio-Miller, A, Padilla, K, Martin, UJ & Gil, EG 2021, 'Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study', American Journal of Respiratory and Critical Care Medicine, vol. 203, A1472. https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472

@article{2a964cf78ee243f695a64bc90cab399a,

title = "Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study",

abstract = "Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes adverse effects, including adrenal insufficiency (AI).",

author = "Mark Gurnell and Andrew Menzies-Gow and Heaney, \{Liam G\} and Jonathan Corren and Bel, \{Elisabeth H\} and Maspero, \{Jorge F\} and Timothy Harrison and David Jackson and David Price and Njira Lugogo and James Kreindler and Annie Burden and \{de Giorgio-Miller\}, Alex and Kelly Padilla and Martin, \{Ubaldo J.\} and Gil, \{Esther Garcia\}",

year = "2021",

doi = "10.1164/ajrccm-conference.2021.203.1\_MeetingAbstracts.A1472",

language = "English",

volume = "203",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

note = "ATS International Conference Committee : ATS 2021 ; Conference date: 14-05-2021 Through 19-05-2021",

url = "https://conference.thoracic.org/",

}

TY - JOUR

T1 - Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

AU - Gurnell, Mark

AU - Menzies-Gow, Andrew

AU - Heaney, Liam G

AU - Corren, Jonathan

AU - Bel, Elisabeth H

AU - Maspero, Jorge F

AU - Harrison, Timothy

AU - Jackson, David

AU - Price, David

AU - Lugogo, Njira

AU - Kreindler, James

AU - Burden, Annie

AU - de Giorgio-Miller, Alex

AU - Padilla, Kelly

AU - Martin, Ubaldo J.

AU - Gil, Esther Garcia

PY - 2021

Y1 - 2021

N2 - Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes adverse effects, including adrenal insufficiency (AI).

AB - Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes adverse effects, including adrenal insufficiency (AI).

U2 - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472

DO - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1472

M3 - Abstract

SN - 1073-449X

VL - 203

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

M1 - A1472

T2 - ATS International Conference Committee

Y2 - 14 May 2021 through 19 May 2021

ER -

Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

Abstract

Access to Document

Fingerprint

Cite this